# Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers

> **NCT02253901** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BILR 355 BS
- **DRUG:** Ritonavir
- **DRUG:** TRUVADA

## Key facts

- **NCT ID:** NCT02253901
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-05
- **Final completion:** —
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253901, "Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02253901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*